Clinical Trial Update: Reduced Chemotherapy in Low Risk DLBCL [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating reduced chemotherapy in patients with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B-cell Lymphoma | Phase 4 | Status: UNKNOWN